Case Reports for Topical Treatment of Corneal Ulcers with a New Matrix Therapy Agent or RGTA® in Dogs
Open Access
- 13 December 2019
- journal article
- case report
- Published by MDPI AG in Veterinary Sciences
- Vol. 6 (4) , 103
Abstract
Superficial corneal ulcers that fail to heal within a normal time period and are refractory to conventional therapy in dogs are common in veterinary practice. Different etiologies can lead to this result, including spontaneous chronic corneal epithelial defects (SCCEDs) and ulcerative keratitis associated with bullous keratopathy. Thus, there is an urgent need to find new therapeutic approaches such as matrix therapy replacement. To determine the efficacy of a new ophthalmic treatment (Clerapliq®) for SCCEDs and ulcerative keratitis associated with bullous keratopathy, a total of 11 dogs referred to the clinic because of nonhealing erosive ulcers after a classic primary treatment were enrolled to get this new treatment. Dogs underwent ophthalmic exams and 7 dogs (10 eyes) were diagnosed with superficial ulceration and 4 dogs (5 eyes) with bullous keratopathy due to endothelial dystrophy/degeneration. They received eye drops of Clerapliq® every 3 days until recovery. The results showed that the corneas with recurrences of the ulcers were resolved predominantly by using Clerapliq® every 3 days in 83.3% of the cases during a period of treatment ranging between 6 to 35 days. Therefore, this new approach using matrix therapy regenerating technology in treating superficial ulcers and bullous keratopathy in dogs can be successfully considered as an adjunctive therapy.Keywords
This publication has 37 references indexed in Scilit:
- Corneal collagen cross‐linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot studyVeterinary Ophthalmology, 2013
- Topical Treatment with a New Matrix Therapy Agent (RGTA) for the Treatment of Corneal Neurotrophic UlcersInvestigative Ophthalmology & Visual Science, 2012
- Histologic evaluation of the immediate effects of diamond burr debridement in experimental superficial corneal wounds in dogsVeterinary Ophthalmology, 2011
- Regenerating matrix-based therapy for chronic wound healing: a prospective within-subject pilot studyInternational Wound Journal, 2010
- Outbreak of ocular disease associated with naturally‐acquired canine herpesvirus‐1 infection in a closed domestic dog colonyVeterinary Ophthalmology, 2009
- Expression of Matrix Metalloproteinase 2 and 9 in Experimentally Wounded Canine Corneas and Spontaneous Chronic Corneal Epithelial DefectsCornea, 2007
- Structure–activity studies of heparan mimetic polyanions for anti-prion therapiesBiochemical and Biophysical Research Communications, 2007
- RGTA OTR4120, a heparan sulfate mimetic, is a possible long‐term active agent to heal burned skinJournal of Biomedical Materials Research Part A, 2006
- Corneal ulceration associated with naturally occurring canine herpesvirus-1 infection in two adult dogsJournal of the American Veterinary Medical Association, 2006
- Efficacy of two chondroitin sulfate ophthalmic solutions in the therapy of spontaneous chronic corneal epithelial defects and ulcerative keratitis associated with bullous keratopathy in dogsVeterinary Ophthalmology, 2006